Schedule 13G ownership disclosure

COEPTIS THERAPEUTICS HLDGS I

COMMON STOCK, PAR VALUE $0.0001 · CUSIP: 19207A108

Event date: 2024-01-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Leonite Fund I, LP

    Shares: 2,050,000.00 · Class: 6.0%

  • Leonite Advisors LLC

    Shares: 2,050,000.00 · Class: 6.0%

  • Geller Avi

    Shares: 2,050,000.00 · Class: 6.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001883076-24-000007
Form type
SCHEDULE 13G
Filer
Coeptis Therapeutics Holdings, Inc.
CIK
CIK 1759186
Filed
Jan 11, 2024
Reporting period
Jan 05, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub